Abstract
Obesity affects obstructive sleep apnea (OSA) via changes in the anatomy and physiology of respiration. Intermittent hypoxia may play a role between OSA and obesity comorbid diseases such as diabetes mellitus, non-alcoholic steatohepatitis (NASH), and pseudotumor cerebri. Obesity and androgen excess are risk factors for OSA in polycystic ovary syndrome (PCOS). Medical or surgical weight loss can lead to improvements in the severity of OSA; however, cure may not be possible and continuous positive airway pressure (CPAP) may still be required. While CPAP may improve metabolic outcomes, there does not appear to be a clear effect of CPAP on weight loss or change in body composition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ogden CL, et al. (2012). Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief (82):1–8.
Young T, et al. The occurrence of sleep disordered breathing among middle aged adults. N Engl J Med. 1993;328(17):1230–5.
Peppard PE, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284:3015–21.
Pillar G, et al. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care. 2008;31:303–9.
Schwab RJ, et al. Upper airway and soft tissue anatomy in normal subjects and patients with sleep disordered breathing. Am J Respir Crit Care Med. 1995;152:1673–89.
Stauffer JL, et al. Morphology of the uvula in obstructive sleep apnea. Am Rev Respir Dis. 1999;140:724–8.
Schwab RJ, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med. 2003;168:522–30.
Schwab RJ, et al. Upper airway and soft tissue structural changes induced by CPAP in normal subjects. Am J Respir Crit Care Med. 1996;154:1106–16.
Ryan CM, et al. Pathogenesis of obstructive sleep apnea. J Appl Physiol. 2005;99:2440–50.
Smith PL, et al. Upper airway pressure flow-relationships in obstructive sleep apnea. J Appl Physiol. 1988;64:789–95.
Schwartz AR, et al. Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol. 1988;64:535–42.
Watanabe T, et al. Contribution of body habitus and craniofacial characteristics to segmental closing pressures of the passive pharynx in patients with sleep disordered breathing. Am J Respir Crit Care Med. 2002;165:260–5.
Mezzanotte WS, et al. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest. 1992;89:1571–9.
McGinley BM, et al. Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apnea. J Appl Physiol. 2008;105:197–205.
Schwartz AR, et al. Acute upper airway responses to hypoglossal nerve stimulation during sleep in obstructive sleep apnea. Am J Respir Crit Care Med. 2012;185:420–6.
Carrera M, et al. Patients with obstructive sleep apnea exhibit genioglossus dysfunction that is normalized after treatment with continuous positive airway pressure. Am J Respir Crit Care Med. 1999;159:1960–6.
Kimura H, et al. Differences in the response of genioglossal muscle activity to sustained hypoxia between healthy subjects and patients with obstructive sleep apnea. Respiration. 1994;61:155–60.
Edström L, et al. Neurogenic effects on the palatopharyngeal muscle in patients with obstructive sleep apnoea: a muscle biopsy study. J Neurol Neurosurg Psychiatry. 1992;55:916–20.
Boyd JH, et al. Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170:541–6.
Sharma SK, et al. A stepped approach for prediction of obstructive sleep apnea in overtly asymptomatic obese subjects: a hospital based study. Sleep Med. 2004;5:351–7.
Sergi M, et al. Sleep apnea in moderate-severe obese patients. Sleep Breath. 1999;3:47–52.
Schwartz AR, et al. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc. 2008;5:185–92.
Steier J, et al. Neural respiratory drive in obesity. Thorax. 2009;64:719–25.
Khoo MC, et al. Factors inducing periodic breathing in humans: a general model. J Appl Physiol. 1982;53:644–59.
Piper AJ, et al. Big breathing: the complex interaction of obesity, hypoventilation, weight loss and respiratory function. J Appl Physiol. 2010;108:199–205.
Tasali E, et al. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008;133(2):496–506.
Liu A, et al. Habitual shortened sleep and insulin resistance: an independent relationship in obese individuals. Metabolism. 2013;62(11):1553–6.
Stamatakis K. Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep. 2008;31:1018–24.
Drager LF, et al. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity. 2011;19:2167–74.
Iiyri N, et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med. 2007;175:851–7.
Xu J, et al. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic Biol Med. 2009;46:783–90.
Bonsignore MR, et al. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J. 2012;39(5):1136–43.
Cizza G, et al. Obstructive sleep apnea is a predictor of abnormal glucose metabolism in chronically sleep deprived obese adults. PLoS One. 2013;8(5):e65400.
Gastaldelli A, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease and early atherosclerosis in a large European population. Hepatology. 2009;49:1537–44.
Mirrakhimow EA, et al. Obstructive sleep apnea and non-alcoholic fatty liver disease: is the liver another target? Front Neurol. 2012;3:149.
Polotsky VY, et al. Obstructive sleep apnea, insulin resistance and steatohepatitis in severe obesity. Am J Respir Crit Care Med. 2009;179:228–34.
Weingarten TN, et al. Nonalcoholic steatohepatitis in bariatric patients with a diagnosis of obstructive sleep apnea. Obes Facts. 2012;5(4):587–96.
Aron-Wisnewsky J, et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol. 2012;56(1):225–33.
Kapsimalis F, Kryger MH. Gender and obstructive sleep apnea syndrome, part 2: mechanisms. Sleep. 2002;25(5):499–506.
Ehrman D. Metabolic dysfunction in PCOS: relationship to obstructive sleep apnea. Steroids. 2012;77(4):290–4.
Fogel RB, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(3):1175–80.
Mokhlesi B, et al. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women. Fertility & Sterelity. 2012;97(3):786–91.
Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab. 2001;86:517–20.
Purvin VA, et al. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol. 2000;118(12):1626–30.
Sugita Y, et al. Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electroencephalogr Clin Neurophysiol. 1985;60(3):214–9.
Thurtell MJ, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol. 2013;260(7):1748–51.
Mechanick JI, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2013;9(2):159–91.
Marceau P, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947–54.
Sjöström L, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;2004(351):2683–93.
Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219–34.
Sarkhosh K, et al. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Obes Surg. 2013;23:414–23.
Buchwald H, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;14:1724–37.
Greenburg DL, et al. Effects of surgical weight loss on measure of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122:535–42.
Newman AB, et al. Progression and regression of sleep-disordered breathing with changes in weight. Arch Intern Med. 2005;165:2408–13.
Dixon JB, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308:1142–9.
Sjöström L. Analysis of the XENDOS study (Xenical in the prevention of diabetes in obese subjects). Endocr Pract. 2006;12(Suppl):31–3.
Svendsen M, et al. Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders. Nutr J. 2011;10:21.
Hollander PA, Elbein SC, Hirsch IB, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care 1998;21(8):1288–94.
Fidler MC, et al. A one-year trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endorinol Metab. 2011;96:3067–77.
Allison DB, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity. 2012;20(2):330–42.
Winslow DH, et al. A randomized, double-blind placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults. Sleep. 2012;35:1529–39.
2 new drugs for weight loss. Med Lett Drugs Ther 2012; 54: 69–71.
Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med. 2002;346:393–403.
Group DP. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–86.
Tuomilehto HP, et al. Lifestyle intervention with weight reduction. First-line treatment with mild obstructive sleep apnea. Am J Respir Crit Care Med. 2009;179:320–7.
Johansson K, Neovius M, Lagerro YT, et al. Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomized controlled trial. BMJ 2009;339:b4609.
Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes. Arch Intern Med 2009;169(17):1619–26.
Awad KM, Malhotra A, Barnet JH, et al. Exercise is associated with a reduced incidence of sleep-disordered breathing. Am J Med 2012;125:485–90.
Kline CE, Crowley EP, Ewing GB, et al. The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial. Sleep 2011;34:1631–40.
Peppard PE, Young TY. Exercise and sleep-disordered breathing: an association independent of body habitus. Sleep 2004;27:480–84.
Quan S, O’Connor GT, Quan JS, et al. Association of physical activity with sleep-disordered breathing. Sleep Breath 2007;11:149–57.
Iftikhar IT, Kline CE, Youngstedt SD. Effects of exercise training on sleep apnea: a meta-analysis. Lung 2014;192:175–84.
Sivam S, et al. Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur Respir J. 2012;40:913–8.
Chin K, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999;100:706–12.
Munzer T, et al. Effects of long-term continuous positive airway pressure on body composition and IGF-1. Eur J Endocrinol. 2010;162(4):695–704.
Garcia JM, et al. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res. 2011;12(1):80.
Lam JC, et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J. 2010;35(1):138–45.
Iftikhar IH, Khan MF, Das A, et al. Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes. Ann Amer Thorac Soc 2013;10:115–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jones, S.F., Brito, V. (2014). Effects of Obesity on OSA and Its Treatment. In: Pagel, J., Pandi-Perumal, S. (eds) Primary Care Sleep Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1185-1_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1185-1_18
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1184-4
Online ISBN: 978-1-4939-1185-1
eBook Packages: MedicineMedicine (R0)